Back
Citius Pharmaceuticals Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
17
CTXR
Citius Pharmaceuticals
Last Price:
0.56
Seasonality Move:
-3.95%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.55 | Sell |
| 50-day SMA: | 0.71 | Sell |
| 200-day SMA: | 0.72 | Sell |
| 8-day EMA: | 0.53 | Buy |
| 20-day EMA: | 0.56 | Sell |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 0.73 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 43.59 | Sell |
| Chaikin Money Flow: | -108168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.6) | Sell |
| Bollinger Bands (100): | (0.55 - 0.81) | Sell |
Citius Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.55 while CTXR 8-day simple moving average is 0.52, which is a Buy signal.
- The stock price of CTXR is 0.55 while Citius Pharmaceuticals 20-day SMA is 0.55, which makes it a Sell.
- Citius Pharmaceuticals 50-day simple moving average is 0.71 while CTXR share price is 0.55, making it a Sell technically.
- CTXR stock price is 0.55 and Citius Pharmaceuticals 200-day simple moving average is 0.72, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
17
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.55. The Score for CTXR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
99.06M
Price in USD:
0.55
Share Volume:
1.8M
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.07
52-Week Low:
0.48
Sell
17
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.55 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.55 while CTXR 8-day exponential moving average is 0.53, which is a Buy signal.
- The stock price of CTXR is 0.55 while Citius Pharmaceuticals 20-day EMA is 0.56, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.63 while CTXR share price is 0.55, making it a Sell technically.
- CTXR stock price is 0.55 and Citius Pharmaceuticals 200-day simple moving average is 0.73, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 43.59, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.52 - 0.6), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.55 - 0.81), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.